Source Characteristics of Atmospheric CO(2)and CH(4)in a Northeastern Highland Area of South Korea

This study aims to present the atmospheric CO(2)and CH(4)levels and analyze their source characteristics at an observation station in a northeastern highland area of Korea for the 2012-2014 period. We summarized the measured CO(2)and CH(4)concentrations for the 2012-2014 period. In addition, we characterized the major source of the rise of CO(2)and CH(4)in Ganseong (GS) by employing bivariate polar plots (BPP) and the concentration weighted trajectory (CWT) method together with currently available information on emission sources. For the three years, CO(2)was generally high in the order of winter, spring, autumn and summer and CH(4)high in the order of winter, autumn, spring and summer. The observed positive correlations between the hourly CO(2)and CH(4)in every season suggested the possibility of shared common emission sources, but there is a necessity for elucidation on this in the future. The BPP analysis indicated the local sources that are likely to be associated with the rise of greenhouse gases (GHGs) observed at GS (combustion in the village, plant respirations nearby GS, and mobile emissions on the nearby road for CO(2)and leakages from the gas stations along the road and agricultural activities for CH4). Synthesizing the CWT results together with emission source information from national and global emission inventories, we identified likely major source areas and characterized major emission sources. For example, the identified major sources for the winter CO(2)are coal combustion, coal washing and industrial activities in Inner Mongolia, northern and the northeastern China, fuel burning for the energy for the infrastructure of a northwestern city in South Korea, and the manufacturing industry and fuel combustion in the northern parts of North Korea. Hopefully, these kinds of results will aid environmental researchers and decision-makers in performing more in-depth studies for GHG sources in order to derive effective mitigation strategies

Highly controllable transparent and conducting thin films using layer-by-layer assembly of oppositely charged reduced graphene oxides

A new approach for the fabrication of reduced graphene oxide (rGO) multilayers which can be used for transparent and conducting thin films was developed. This was achieved by using layer-by-layer (LbL) assembly of positively and negatively charged rGO sheets, which could provide highly controllable thin films in terms of thickness, transmittance, and sheet resistance. In particular, the thickness of the multilayer thin films of rGO was able to be controlled precisely in the subnanometre scale by similar to 0.46 nm via simply varying the number of stacking layers. Therefore, this method enabled an excellent control of the rGO multilayers over the optical and electrical properties, which are related to the thickness. Furthermore, we demonstrated the application of the rGO multilayers for an OLED device.close585

Seroprevalence of Hepatitis B Virus among Health Care Workers in Korea

We studied the seroprevalence of HBsAg, anti-HBs and anti-HBc and the vaccination histories among health care workers (HCWs) at a large suburban referral hospital in Korea. The purpose of this study was to determine the immune status of HCWs against hepatitis B virus and we also wanted to prepare a practical guideline to protect HCWs from occupational exposure. During December, 2003, 571 HCWs (56 physicians, 289 nurses, 113 technicians and 113 aid-nurses) aged between 21 and 74 yr were included in the surveillance. The positive rates of HBsAg and anti-HBs were 2.4% (14/571) and 76.9% (439/571), respectively. The positive rate of anti-HBs was lower in the physician group, and this was associated with the male gender and older age. Of the 439 anti-HBs positive cases, 320 cases (73.1%) were anti-HBc negative and this was significantly associated with a past history of HBV vaccination. The distribution of the anti-HBs levels was not associated with age (except for HCWs in their sixties), gender or occupation. Our study revealed that the seroprevalence rates of HBsAg and anti-HBs in HCWs in Korea were not different from those of the general population. Based on this surveillance, we can make reasonable decisions in case of occupational exposure to hepatitis B virus

Enhanced optical response of hybridized VO2/graphene films

Application of graphene as transparent electrodes is an active research area due to its excellent electrical and optical properties. Vanadium dioxide (VO2) is an attractive material since it is a thermochromic material that undergoes a structural phase transition when heat is applied. The phase transition results in the change of electrical and optical characteristics. We report optical characteristics of hybrid materials of graphene and VO2. We observed a 12% improvement in infrared transmittance with VO2 films deposited on graphene sapphire substrates compared to that of bare sapphire substrates. We also found that the phase transition temperature decreases as the number of graphene layers on the substrates increases. In the case of VO2 films on the substrate that was coated with four layers of graphene, the mean phase transition temperature was lowered to similar to 56 degrees C.close4

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis:Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

Objective: To investigate the efficacy and safety of ixekizumab in patients with active radiographic axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of 1 or 2 tumor necrosis factor inhibitors (TNFi). Methods: In this phase III randomized, double-blind, placebo-controlled trial, adult patients with an inadequate response to or intolerance of 1 or 2 TNFi and an established diagnosis of axial SpA (according to the Assessment of SpondyloArthritis international Society [ASAS] criteria for radiographic axial SpA, with radiographic sacroiliitis defined according to the modified New York criteria and ≥1 feature of SpA) were recruited and randomized 1:1:1 to receive placebo or 80-mg subcutaneous ixekizumab every 2 weeks (IXEQ2W) or 4 weeks (IXEQ4W), with an 80-mg or 160-mg starting dose. The primary end point was 40% improvement in disease activity according to the ASAS criteria (ASAS40) at week 16. Secondary outcomes and safety were also assessed. Results: A total of 316 patients were randomized to receive placebo (n = 104), IXEQ2W (n = 98), or IXEQ4W (n = 114). At week 16, significantly higher proportions of IXEQ2W patients (n = 30 [30.6%]; P = 0.003) or IXEQ4W patients (n = 29 [25.4%]; P = 0.017) had achieved an ASAS40 response versus the placebo group (n = 13 [12.5%]), with statistically significant differences reported as early as week 1 with ixekizumab treatment. Statistically significant improvements in disease activity, function, quality of life, and spinal magnetic resonance imaging–evident inflammation were observed after 16 weeks of ixekizumab treatment versus placebo. Treatment-emergent adverse events (AEs) with ixekizumab treatment were more frequent than with placebo. Serious AEs were similar across treatment arms. One death was reported (IXEQ2W group). Conclusion: Ixekizumab treatment for 16 weeks in patients with active radiographic axial SpA and previous inadequate response to or intolerance of 1 or 2 TNFi yields rapid and significant improvements in the signs and symptoms of radiographic axial SpA versus placebo